The invention relates to transgenic mammals characterized by 5-HT.sub.3 receptor over-expression in the central nervous system (CNS). The mammals have particular utility as models for studying the role of 5-HT.sub.3 receptors in the CNS, especially for the study of reward pathways for alcohol and other substances of abuse.